We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNN icon
1526
CALL
Denison Mines
DNN
$2.95B
$41K ﹤0.01%
28,200
+11,900
+73% +$14.4K
HYMCW
1527
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$39K ﹤0.01%
111,970
-10,708
-9% -$3.96K
TMCWW
1528
TMC The Metals Company Warrants
TMCWW
$971K
$39K ﹤0.01%
40,685
+22,540
+124% +$30.4K
SOLO
1529
CALL
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$39K ﹤0.01%
10,900
-100
-0.9% -$354
EACPW
1530
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$39K ﹤0.01%
66,451
GPCOR
1531
DELISTED
Golden Path Acquisition Corporation Rights
GPCOR
$39K ﹤0.01%
+100,000
New +$36.6K
GNW icon
1532
Genworth Financial
GNW
$3.75B
$38K ﹤0.01%
10,000
PNTM.WS
1533
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$38K ﹤0.01%
52,430
XWEL icon
1534
CALL
XWELL
XWEL
$8.06M
$37K ﹤0.01%
1,265
-1,335
-51% -$42.9K
UPH
1535
CALL
DELISTED
UpHealth, Inc.
UPH
$36K ﹤0.01%
+1,130
New +$59K
ATOS icon
1536
CALL
Atossa Therapeutics
ATOS
$23.6M
$34K ﹤0.01%
687
-140
-17% -$8.14K
AENTW icon
1537
Alliance Entertainment Holding Corp Warrants
AENTW
$3.78M
$33K ﹤0.01%
60,680
+50
+0.1% +$32
HYMC icon
1538
Hycroft Mining Holding Corp
HYMC
$2.54B
$33K ﹤0.01%
+2,220
New +$45.1K
GLTA.WS
1539
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$33K ﹤0.01%
+75,000
New +$34.6K
NAK
1540
Northern Dynasty Minerals
NAK
$953M
$32K ﹤0.01%
69,050
-600
-0.9% -$264
GCACW
1541
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$32K ﹤0.01%
31,627
+5,000
+19% +$3.92K
AAQC.WS
1542
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$31K ﹤0.01%
33,333
LGACW
1543
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$30K ﹤0.01%
36,579
PAYOW
1544
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$29K ﹤0.01%
+15,000
New +$32.8K
DS
1545
PUT
DELISTED
Drive Shack Inc.
DS
$29K ﹤0.01%
+10,400
New +$28K
PSTH.WS
1546
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$29K ﹤0.01%
+22,661
New +$67.4K
SRZNW icon
1547
Surrozen Inc Warrant
SRZNW
$8.86K
$28K ﹤0.01%
+24,614
New +$33.8K
DMK
1548
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$28K ﹤0.01%
407
-987
-71% -$72.2K
OPA.WS
1549
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$28K ﹤0.01%
23,924
-6,976
-23% -$6.29K
CLAQR
1550
DELISTED
CleanTech Acquisition Corp. Rights
CLAQR
$28K ﹤0.01%
+117,000
New +$25.2K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.